Sort
78,016 grants matching “breast cancer”
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
$682,662Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Statistical Informatics for Cancer Research
$682,555Xihong Lin · Harvard School Of Public Health · P01 · FY2009 · CA
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer
$682,549Jonine Lisa Bernstein · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
A nested case-control study of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and breast cancer risk in the Multiethnic Cohort
$682,533Eunjung Lee · University Of Southern California · R01 · FY2023 · CA
Enhancing physical activity after breast cancer diagnosis: randomized trial
$682,529Laura Q Rogers · Southern Illinois University Sch Of Med · R01 · FY2010 · CA
Optimizing Lung Cancer Screening in Cancer Survivors
$682,511Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
SWAD: Large-Area Photon Counting X-Ray Imager using Amorphous Selenium
$682,459Amirhossein Goldan · State University New York Stony Brook · R01 · FY2019 · EB
Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
$682,376Kornelia Polyak · Dana-Farber Cancer Inst · U01 · FY2015 · CA
Brain Tumors - Immunological and Biological Studies
$682,341Darell D Bigner · Duke University · R37 · FY2011 · CA
Digital Pathology_Accuracy Viewing Behavior and Image Characterization
$682,340Joann G Elmore · University Of Washington · R01 · FY2013 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema
$682,266Michael Vitoldovich Paukshto · Fibralign Corporation · R44 · FY2021 · CA
Integrating genomic and transcriptomic data to identify breast cancer susceptibility genes
$682,224Wei Zheng · Vanderbilt University Medical Center · R01 · FY2019 · CA
Statistical Informatics for Cancer Research
$682,166Xihong Lin · Harvard School Of Public Health · P01 · FY2013 · CA
Development of Best-in-Class Pol-Theta Inhibitors
$682,151Richard T Pomerantz · Thomas Jefferson University · R01 · FY2025 · CA
Every Day Counts: A lifestyle program for women metastatic breast cancer
$682,109Melinda R Stolley · Medical College Of Wisconsin · R01 · FY2022 · CA
Quantitative Biophotonics for Tissue Characterization and Function
$682,022Amir H Gandjbakhche · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Endoscopic Fine-Needle Polarized Scanning Spectroscopy for Pancreatic Cystic Lesions Diagnosis
$681,985Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2021 · EB
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
$681,912Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Commercialization of Human Mammary Basal / Luminal Cell System for Research
$681,907Benjamin M Buehrer · Zen-Bio, Inc. · R44 · FY2010 · CA
Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem
$681,905Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Brain Tumors - Immunological and Biological Studies
$681,848Darell D Bigner · Duke University · R37 · FY2012 · CA